NCBI Protein banner
My NCBIMy NCBI help
[Sign In] [Register]
PubMed Nucleotide Protein Genome Structure PMC Taxonomy OMIM Books
 Search   for    
 Display   Show
  Range: from   to  Features:      
1:  NP_000925Reports  alpha-2-plasmin i...[gi:115583663] BLink, Conserved Domains, Links
LOCUS       NP_000925                491 aa            linear   PRI 21-SEP-2008
DEFINITION  alpha-2-plasmin inhibitor [Homo sapiens].
ACCESSION   NP_000925
VERSION     NP_000925.2  GI:115583663
DBSOURCE    REFSEQ: accession NM_000934.3
KEYWORDS    .
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 491)
  AUTHORS   Barbe,L., Lundberg,E., Oksvold,P., Stenius,A., Lewin,E.,
            Bjorling,E., Asplund,A., Ponten,F., Brismar,H., Uhlen,M. and
            Andersson-Svahn,H.
  TITLE     Toward a confocal subcellular atlas of the human proteome
  JOURNAL   Mol. Cell Proteomics 7 (3), 499-508 (2008)
   PUBMED   18029348
REFERENCE   2  (residues 1 to 491)
  AUTHORS   Marti-Fabregas,J., Borrell,M., Cocho,D., Martinez-Ramirez,S.,
            Martinez-Corral,M., Fontcuberta,J. and Marti-Vilalta,J.L.
  TITLE     Change in hemostatic markers after recombinant tissue-type
            plasminogen activator is not associated with the chance of
            recanalization
  JOURNAL   Stroke 39 (1), 234-236 (2008)
   PUBMED   18048863
  REMARK    GeneRIF: Thrombin activatable fibrinolysis inhibitor and
            alpha(2)-antiplasmin are not markers for recanalization in patients
            with ischemic stroke treated with recombinant tissue-type
            plasminogen activator.
REFERENCE   3  (residues 1 to 491)
  AUTHORS   Maino,A., Garagiola,I., Artoni,A., Al-Humood,S. and Peyvandi,F.
  TITLE     A novel mutation of alpha2-plasmin inhibitor gene causes an
            inherited deficiency and a bleeding tendency
  JOURNAL   Haemophilia 14 (1), 166 (2008)
   PUBMED   17961166
  REMARK    GeneRIF: Sequencing analysis revealed the presence of two alpha2-PI
            gene variations, both in the second half of exon 10: a frameshift
            mutation and a G to A transition at nucleotide 11337 in codon 407.
REFERENCE   4  (residues 1 to 491)
  AUTHORS   Nielsen,V.G.
  TITLE     Hydroxyethyl starch enhances fibrinolysis in human plasma by
            diminishing alpha2-antiplasmin-plasmin interactions
  JOURNAL   Blood Coagul. Fibrinolysis 18 (7), 647-656 (2007)
   PUBMED   17890952
  REMARK    GeneRIF: Hydroxyethyl starch (HES) dilution enhances fibrinolysis
            by diminishing alpha2-antiplasmin-plasmin interactions.
REFERENCE   5  (residues 1 to 491)
  AUTHORS   Sazonova,I.Y., Thomas,B.M., Gladysheva,I.P., Houng,A.K. and
            Reed,G.L.
  TITLE     Fibrinolysis is amplified by converting alpha-antiplasmin from a
            plasmin inhibitor to a substrate
  JOURNAL   J. Thromb. Haemost. 5 (10), 2087-2094 (2007)
   PUBMED   17883703
  REMARK    GeneRIF: Fibrinolysis is amplified by converting alpha-antiplasmin
            from a plasmin inhibitor to a substrate
REFERENCE   6  (residues 1 to 491)
  AUTHORS   Christensen,S. and Sottrup-Jensen,L.
  TITLE     Bovine alpha 2-antiplasmin. N-terminal and reactive site sequence
  JOURNAL   FEBS Lett. 312 (1), 100-104 (1992)
   PUBMED   1385210
REFERENCE   7  (residues 1 to 491)
  AUTHORS   Welch,S.K. and Francke,U.
  TITLE     Assignment of the human alpha 2-plasmin inhibitor gene (PLI) to
            chromosome 17, region pter-p12, by PCR analysis of somatic cell
            hybrids
  JOURNAL   Genomics 13 (1), 213-214 (1992)
   PUBMED   1577485
REFERENCE   8  (residues 1 to 491)
  AUTHORS   Wiman,B. and Collen,D.
  TITLE     On the mechanism of the reaction between human alpha 2-antiplasmin
            and plasmin
  JOURNAL   J. Biol. Chem. 254 (18), 9291-9297 (1979)
   PUBMED   158022
REFERENCE   9  (residues 1 to 491)
  AUTHORS   Wiman,B. and Collen,D.
  TITLE     Purification and characterization of human antiplasmin, the
            fast-acting plasmin inhibitor in plasma
  JOURNAL   Eur. J. Biochem. 78 (1), 19-26 (1977)
   PUBMED   21075
REFERENCE   10 (residues 1 to 491)
  AUTHORS   Moroi,M. and Aoki,N.
  TITLE     Isolation and characterization of alpha2-plasmin inhibitor from
            human plasma. A novel proteinase inhibitor which inhibits
            activator-induced clot lysis
  JOURNAL   J. Biol. Chem. 251 (19), 5956-5965 (1976)
   PUBMED   134998
COMMENT     VALIDATED REFSEQ: This record has undergone validation or
            preliminary review. The reference sequence was derived from
            BX107460.1, BC031592.1 and J02654.1.
            On Oct 6, 2006 this sequence version replaced gi:11386143.
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the
            Entrez Gene record to access additional publications.
FEATURES             Location/Qualifiers
     source          1..491
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13"
     Protein         1..491
                     /product="alpha-2-plasmin inhibitor"
                     /note="serine (or cysteine) proteinase inhibitor, clade F
                     (alpha-2 antiplasmin, pigment epithelium derived factor),
                     member 2; alpha-2-antiplasmin"
                     /calculated_mol_wt=54435
     CDS             1..491
                     /gene="SERPINF2"
                     /gene_synonym="AAP"
                     /gene_synonym="API"
                     /gene_synonym="PLI"
                     /gene_synonym="A2AP"
                     /gene_synonym="ALPHA-2-PI"
                     /coded_by="NM_000934.3:78..1553"
                     /db_xref="CCDS:CCDS11011.1"
                     /db_xref="GeneID:5345"
                     /db_xref="HGNC:9075"
                     /db_xref="HPRD:02029"
                     /db_xref="MIM:262850"
ORIGIN      
        1 mallwgllvl swsclqgpcs vfspvsamep lgrqltsgpn qeqvspltll klgnqepggq
       61 talksppgvc srdptpeqth rlarammaft adlfslvaqt stcpnlilsp lsvalalshl
      121 algaqnhtlq rlqqvlhags gpclphllsr lcqdlgpgaf rlaarmylqk gfpikedfle
      181 qseqlfgakp vsltgkqedd laninqwvke ategkiqefl sglpedtvll llnaihfqgf
      241 wrnkfdpslt qrdsfhldeq ftvpvemmqa rtyplrwfll eqpeiqvahf pfknnmsfvv
      301 lvpthfewnv sqvlanlswd tlhpplvwer ptkvrlpkly lkhqmdlvat lsqlglqelf
      361 qapdlrgise qslvvsgvqh qstlelsevg veaaaatsia msrmslssfs vnrpflffif
      421 edttglplfv gsvrnpnpsa prelkeqqds pgnkdflqsl kgfprgdklf gpdlklvppm
      481 eedypqfgsp k
//

Disclaimer | Write to the Help Desk
NCBI | NLM | NIH

 

Last update: Wed, 05 Nov 2008 Rev. 145015